Stockreport

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19 [Yahoo! Finance]

Evolus, Inc.  (EOLS) 
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
PDF IRVINE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a biopharmaceutical company developing ABP-450 (prabotuli [Read more]